Literature DB >> 8484793

Mutation of arginine 86 to proline in the insulin receptor alpha subunit causes lack of transport of the receptor to the plasma membrane, loss of binding affinity and a constitutively activated tyrosine kinase in transfected cells.

K Grønskov1, H Vissing, R M Shymko, H Tornqvist, P De Meyts.   

Abstract

We have investigated the role of Ser 85 and Arg 86 of the human insulin receptor (HIR) in insulin binding and tyrosine kinase activity by mutational analysis. Four mutant cDNAs were created (R86P, R86N, S85T+R86N, S85W+R86K) and stably transfected into BHK cells. R86P-HIR was also transiently expressed in 293 cells. Only the R86P receptor had substantially altered properties: lack of transport to the plasma membrane, loss of insulin binding, a constitutively activated autophosphorylation and tyrosine kinase, and an incomplete processing. Some of these alterations mimic those reported for the insulin receptor of the leprechaun Atl, which has a homozygous R86P mutation (Longo, N., et al, Biochem. Biophys. Res. Commun., 167, 1229, 1990; Clin. Res., 40, 2, 329, 1992).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484793     DOI: 10.1006/bbrc.1993.1501

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Authors:  Meizhen Lou; Thomas P J Garrett; Neil M McKern; Peter A Hoyne; V Chandana Epa; John D Bentley; George O Lovrecz; Leah J Cosgrove; Maurice J Frenkel; Colin W Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

Review 2.  Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.

Authors:  Ana Pérez-García; Marta Torrecilla-Parra; Mario Fernández-de Frutos; Yolanda Martín-Martín; Virginia Pardo-Marqués; Cristina M Ramírez
Journal:  Biomolecules       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.